# Emollients in the Management of Atopic Dermatitis

> **NCT01779258** · PHASE3 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 347 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** glycerol, paraffin (liquid and white soft)
- **DEVICE:** Atopiclair®
- **DRUG:** Locatop@
- **DRUG:** Locapred@

## Key facts

- **NCT ID:** NCT01779258
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 347 (ACTUAL)
- **Last updated:** 2014-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01779258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01779258, "Emollients in the Management of Atopic Dermatitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01779258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*